The Discounted Cash Flow (DCF) valuation of Kymera Therapeutics Inc (KYMR) is (171.91) USD. With the latest stock price at 45.02 USD, the upside of Kymera Therapeutics Inc based on DCF is -481.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 8.7% | 7.8% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (349.44) - (115.26) | (171.91) |
| Upside | -876.3% - -356.0% | -481.9% |